135 related articles for article (PubMed ID: 1647952)
41. Life threatening diarrhoea ultimately cured by surgery.
Sjöqvist U; Permert J; Löfberg R; Larsson J; Gadaleanu V; Adrian TE
Eur J Gastroenterol Hepatol; 1998 Nov; 10(11):963-7. PubMed ID: 9872620
[TBL] [Abstract][Full Text] [Related]
42. Production of VIP- and PHM (human PHI)-related peptides in human neuroblastoma cells.
Hoshino M; Yanaihara C; Ogino K; Iguchi K; Sato H; Suzuki T; Yanaihara N
Peptides; 1984; 5(2):155-60. PubMed ID: 6548020
[TBL] [Abstract][Full Text] [Related]
43. [Vipomas].
Dupont C
Ann Med Interne (Paris); 1984; 135(5):400-2. PubMed ID: 6091517
[TBL] [Abstract][Full Text] [Related]
44. A new bioassay of VIP: results in watery diarrhoea syndrome.
Laburthe MC; Dupont CM; Besson JD; Rousset M; Rosselin GE
Gut; 1980 Jul; 21(7):619-23. PubMed ID: 7429326
[TBL] [Abstract][Full Text] [Related]
45. Vasoactive intestinal peptide receptor scintigraphy in patients with pancreatic adenocarcinomas or neuroendocrine tumours.
Hessenius C; Bäder M; Meinhold H; Böhmig M; Faiss S; Reubi JC; Wiedenmann B
Eur J Nucl Med; 2000 Nov; 27(11):1684-93. PubMed ID: 11105825
[TBL] [Abstract][Full Text] [Related]
46. Distribution, plasma concentration, and in vivo prolactin-releasing activity of peptide histidine methionine in humans.
Sasaki A; Sato S; Go MG; Shimizu Y; Murakami O; Hanew K; Yumita S; Andoh N; Sasano N; Yoshinaga K
J Clin Endocrinol Metab; 1987 Oct; 65(4):683-8. PubMed ID: 3654914
[TBL] [Abstract][Full Text] [Related]
47. Structure and expression of the gene encoding the vasoactive intestinal peptide precursor.
Linder S; Barkhem T; Norberg A; Persson H; Schalling M; Hökfelt T; Magnusson G
Proc Natl Acad Sci U S A; 1987 Jan; 84(2):605-9. PubMed ID: 3025882
[TBL] [Abstract][Full Text] [Related]
48. Successful treatment of therapy-resistant pancreatic cholera with human leucocyte interferon.
Oberg K; Alm G; Lindström H; Lundqvist G
Lancet; 1985 Mar; 1(8431):725-7. PubMed ID: 2857998
[TBL] [Abstract][Full Text] [Related]
49. [The VIP-secreting tumor as a differential diagnosis of protracted diarrhea in pediatrics].
Reindl T; Degenhardt P; Luck W; Riebel T; Sarioglu N; Henze G; Driever PH
Klin Padiatr; 2004; 216(5):264-9. PubMed ID: 15455292
[TBL] [Abstract][Full Text] [Related]
50. Complete nucleotide sequence of human vasoactive intestinal peptide/PHM-27 gene and its inducible promoter.
Yamagami T; Ohsawa K; Nishizawa M; Inoue C; Gotoh E; Yanaihara N; Yamamoto H; Okamoto H
Ann N Y Acad Sci; 1988; 527():87-102. PubMed ID: 2839091
[TBL] [Abstract][Full Text] [Related]
51. Clinicopathological data and treatment modalities for pancreatic vipomas: a systematic review.
Schizas D; Mastoraki A; Bagias G; Patras R; Moris D; Lazaridis II; Arkadopoulos N; Felekouras E
J BUON; 2019; 24(2):415-423. PubMed ID: 31127985
[TBL] [Abstract][Full Text] [Related]
52. Vasoactive intestinal polypeptide-secreting tumours: biology and therapy.
Park SK; O'Dorisio MS; O'Dorisio TM
Baillieres Clin Gastroenterol; 1996 Dec; 10(4):673-96. PubMed ID: 9113317
[TBL] [Abstract][Full Text] [Related]
53. Vasoactive intestinal peptide (VIP) and peptide histidine methionine (PHM) in human eccrine sweat glands: demonstration of innervation, specific binding sites and presence in secretions.
Eedy DJ; Shaw C; Armstrong EP; Johnston CF; Buchanan KD
Br J Dermatol; 1990 Jul; 123(1):65-76. PubMed ID: 2390496
[TBL] [Abstract][Full Text] [Related]
54. Multiple-hormone gene expression in ganglioneuroblastoma with watery diarrhea, hypokalemia, and achlorhydria syndrome.
Kimura N; Yamamoto H; Okamoto H; Wakasa H; Nagura H
Cancer; 1993 May; 71(9):2841-6. PubMed ID: 7682155
[TBL] [Abstract][Full Text] [Related]
55. Vasoactive intestinal polypeptide and peptide histidine methionine. Presence in human follicular fluid and effects on DNA synthesis and steroid secretion in cultured human granulosa/lutein cells.
Gräs S; Ovesen P; Andersen AN; Sørensen S; Fahrenkrug J; Ottesen B
Hum Reprod; 1994 Jun; 9(6):1053-7. PubMed ID: 7962375
[TBL] [Abstract][Full Text] [Related]
56. Expression and characterization of VIP and two VIP mutants in NIH 3T3 cells.
Wulff BS; Georg B; Fahrenkrug J
FEBS Lett; 1994 Mar; 341(1):43-8. PubMed ID: 8137920
[TBL] [Abstract][Full Text] [Related]
57. VIP measurement in distinguishing Verner-Morrison syndrome and pseudo Verner-Morrison syndrome.
Bloom SR; Polak JM
Clin Endocrinol (Oxf); 1976; 5 Suppl():223S-228S. PubMed ID: 212228
[TBL] [Abstract][Full Text] [Related]
58. [Diagnosis of Verner-Morrison syndrome (VDHA) and its treatment with sandostatin an streptozocitin].
Várkonyi TT; Velösy B; Nagy I; Németh J; Lonovics J
Orv Hetil; 1993 Nov; 134(47):2599-602. PubMed ID: 8247522
[TBL] [Abstract][Full Text] [Related]
59. Variable distribution, in four rat brain areas, of the three natural forms of peptide histidine isoleucinamide: PHI(1-27)NH2, PHI-Gly, and PHV (1-42).
Cauvin A; De Neef P; Bastianelli E; Robberecht P; Christophe J
Neuroendocrinology; 1991 Feb; 53(2):190-3. PubMed ID: 1901633
[TBL] [Abstract][Full Text] [Related]
60. Vasoactive intestinal peptide secreting tumours in children: a case report with literature review.
Quak SH; Prabhakaran K; Kwok R; O'Reilly AP
Aust Paediatr J; 1988 Feb; 24(1):55-8. PubMed ID: 2833214
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
